Particle sizes of infectious aerosols: implications for infection control - The Lancet Respiratory Medicine
Descrição
Healthcare-associated infection impact with bioaerosol treatment and COVID-19 mitigation measures - ScienceDirect
Airborne Transmission of SARS-CoV-2: Proceedings of a Workshopin Brief, Airborne Transmission of SARS-CoV-2: Proceedings of a Workshop—in Brief
Airborne transmission of respiratory viruses
Particle sizes of infectious aerosols: implications for infection control - The Lancet Respiratory Medicine
What is the evidence to support the 2-metre social distancing rule to reduce COVID-19 transmission? - The Centre for Evidence-Based Medicine
The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions - The Lancet Respiratory Medicine
A roadmap to pulmonary delivery strategies for the treatment of infectious lung diseases, Journal of Nanobiotechnology
IJERPH, Free Full-Text
Reducing transmission of SARS-CoV-2
Aerosol Particles Generated by Coughing and Sneezing of a SARS-CoV-2 (COVID-19) Host Travel over 30 m Distance - Aerosol and Air Quality Research
Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable tuberculosis: a prospective cohort study - The Lancet Respiratory Medicine
Recognition of aerosol transmission of infectious agents: a commentary, BMC Infectious Diseases
Efficacy of masks and face coverings in controlling outward aerosol particle emission from expiratory activities
de
por adulto (o preço varia de acordo com o tamanho do grupo)
